<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-31T15:16:29Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/20828" metadataPrefix="rdf">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/20828</identifier><datestamp>2026-02-03T12:32:41Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37959</setSpec></header><metadata><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
   <ow:Publication rdf:about="oai:riuma.uma.es:10630/20828">
      <dc:title>Galanin (1-15) enhances the behavioural effects of escitalopram in the forced swimming test in rats</dc:title>
      <dc:creator>García-Durán, Laura</dc:creator>
      <dc:creator>Cantero-García, Noelia</dc:creator>
      <dc:creator>Flores-Burgess, Antonio</dc:creator>
      <dc:creator>Gago-Calderón, Belén</dc:creator>
      <dc:creator>Puigcerver-Martínez, Araceli</dc:creator>
      <dc:creator>Narváez-Bueno, José Ángel</dc:creator>
      <dc:creator>Santín-Núñez, Luis Javier</dc:creator>
      <dc:creator>Millón-Peñuela, Carmelo</dc:creator>
      <dc:creator>Díaz-Cabiale,  Zaida</dc:creator>
      <dc:subject>Biomedicina -- Investigación</dc:subject>
      <dc:description>The selective serotonergic reuptake inhibitors (SSRIs) are the most commonly used for the&#xd;
treatment of major depression. Recently, we observed that the Galanin N-terminal fragment&#xd;
(1-15) [GAL(1-15)] enhances the antidepressant-like effects induced by Fluoxetine&#xd;
(FLX) in the forced swimming test (FST) (Flores-Burgess et al, 2017). Therefore, we have&#xd;
analyzed the ability of GAL(1-15) to enhance the behavioural effects of Escitalopram&#xd;
(ESC), other SSRIs, in the FST and the tail suspension test (TST).&#xd;
In the first set of experiments, groups of rats received three injections (23, 5 and 1 hour)&#xd;
before FST of two different doses of ESC (5mg/Kg or 7,5mg/Kg) or vehicle to perform a&#xd;
dose-response curve in the FST. Secondly, different groups of rats received three injections&#xd;
of ESC (7,5mg/Kg) and a single injection of a threshold dose of GAL(1-15) (1nmol) or&#xd;
aCSF 15 minutes before the FST and TST.&#xd;
In the dose-response curve, ESC 5 mg/kg and 7,5 mg/kg significantly increase the swimming&#xd;
time (p&lt;0.05), while lacking effects over immobility time. The threshold dose of&#xd;
GAL(1-15) 1nmol enhanced the antidepressant-like effects mediated by ESC 7,5mg/Kg,&#xd;
decreasing the immobility (p&lt;0.05) and increasing the swimming time (p&lt;0.05) in the FST.&#xd;
In TST, no differences were found between the treatments.&#xd;
Our results indicate an interaction between GAL(1-15) and ESC in the FST and open up&#xd;
the possibility to use GAL(1-15) for a combination therapy with SSRIs as a depression&#xd;
treatment.</dc:description>
      <dc:date>2021-01-22T15:52:41Z</dc:date>
      <dc:date>2021-01-22T15:52:41Z</dc:date>
      <dc:date>2021-01</dc:date>
      <dc:date>2021-01-22</dc:date>
      <dc:type>conference output</dc:type>
      <dc:identifier>https://hdl.handle.net/10630/20828</dc:identifier>
      <dc:language>eng</dc:language>
      <dc:relation>FENS</dc:relation>
      <dc:relation>Glasgow</dc:relation>
      <dc:relation>Julio 2020</dc:relation>
      <dc:rights>open access</dc:rights>
   </ow:Publication>
</rdf:RDF>
</metadata></record></GetRecord></OAI-PMH>